Microvast Securities Fraud Investigation
Analysis based on 6 articles · First reported Apr 02, 2026 · Last updated Apr 21, 2026
The market is negatively impacted by the significant drop in Microvast's stock price due to poor financial results and the subsequent investigation by Pomerantz LLP. This event highlights potential risks for investors in companies with unexpected financial downturns and regulatory challenges.
Pomerantz LLP is investigating Microvast for securities fraud and unlawful business practices. This follows Microvast's announcement of its fourth quarter and full year 2025 financial results on March 16, 2026, which revealed a 15% year-over-year revenue decrease to $96.5 million, falling short of consensus estimates. The company's gross margin also sharply declined to approximately 1% from 36% in the prior year, attributed to inventory impairment charges. Microvast cited regulatory shifts in South Korea and delays in customer platform ramp-up in Europe, the Middle East, and Africa as reasons for the revenue decline. Following this news, Microvast's stock price plummeted by 34.2% to $1.52 per share on March 17, 2026.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard